This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Sandoz Rizatriptan ODT (2016-10-12)

Starting date:: October 12, 2016
Posting date:: October 24, 2016
Type of communication:: Drug Recall
Subcategory:: Drugs
Hazard classification:: Type III
Source of recall:: Health Canada
Issue:: Product Safety
Audience:: General Public, Healthcare Professionals, Hospitals
Identification number:: RA-60736

Reason
Depth of distribution
Affected products

Affected Products

Reason

Out of specification result for the assay during stability testing

Depth of distribution

Wholesalers and pharmacies in Canada

Affected products

Sandoz Rizatriptan ODT

DIN, NPN, DIN-HIM

DIN 02351870

Dosage form

Orally Disintegrating Tablet

Strength

5 mg

Lot or serial number

GG0804

Companies

Recalling Firm

Sandoz Canada Inc.

145 Jules-Léger

Boucherville

J4B 7K8

Quebec

CANADA

Marketing Authorization Holder